Novavax (NVAX) Shares Issued: 2009-2024
Historic Shares Issued for Novavax (NVAX) over the last 12 years, with Jun 2024 value amounting to $256.4 million.
- Novavax's Shares Issued rose 313.66% to $256.4 million in Q2 2024 from the same period last year, while for Jun 2024 it was $428.5 million, marking a year-over-year decrease of 51.09%. This contributed to the annual value of $263.3 million for FY2024, which is 26.92% down from last year.
- According to the latest figures from Q2 2024, Novavax's Shares Issued is $256.4 million, which was up 3,636.67% from $6.9 million recorded in Q1 2024.
- Novavax's Shares Issued's 5-year high stood at $564.9 million during Q1 2021, with a 5-year trough of $1.5 million in Q2 2020.
- In the last 3 years, Novavax's Shares Issued had a median value of $86.5 million in 2022 and averaged $113.0 million.
- Its Shares Issued has fluctuated over the past 5 years, first skyrocketed by 49,900.00% in 2020, then crashed by 68.24% in 2022.
- Quarterly analysis of 5 years shows Novavax's Shares Issued stood at $428.6 million in 2020, then spiked by 203.82% to $564.9 million in 2021, then crashed by 68.24% to $69.8 million in 2022, then soared by 47.82% to $103.2 million in 2023, then soared by 313.66% to $256.4 million in 2024.
- Its Shares Issued stands at $256.4 million for Q2 2024, versus $6.9 million for Q1 2024 and $103.2 million for Q4 2023.